ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993

Conference asks NCAB To Develop Guidelines For Clinical Alerts; Must Be Investigator-Initiated

February 9, 1990

Hew Proposes New Rules For Pregnant Women, Fetuses, Prisoners In Research

August 30, 1974

President Obama Signs Recalcitrant Cancer Bill

January 4, 2013

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

In Brief: Paul Sugarbaker to Head New DC Cancer Center; Michael Shimkin Dies; Tel Aviv Conference “Safe”

January 27, 1989